The modern company would have offered money and teddy bears to children to participate in studies for the anti-Covid vaccine

The modern company, producing the vaccine against Covid-19, could be suspended or even excluded from the British Pharmaceutical Industry Association (ABPI), after a series of regulatory code violations “Completely unacceptable” by the supervisory authorities. The modern would have offered money and teddy bears to children to participate in clinical studies for the anti-Covid vaccine.

The modern company is accused of serious irregularities. Photo: Archive

The modern is to be subjected to a complete audit on the organizational culture, governance and its compliance, according to the Authority the Code on drugs issued on a prescription (PMCPA). The decision comes after several serious irregularities, including providing amounts of 1500 pounds and teddy bears to participate in clinical studies for the anti-Covid vaccine. These practices are forbidden by the regulations in force, notes The Telegraph.

In a new decision, which will be published soon, PMCPA has found that Modern has misled authorities about the moment when it learned about offering financial incentives to children. Although the company claimed that it took measures immediately after it was officially notified in January 2024, it turned out that members of the management had been informed since August 2023 by the non-profit organization USFORTHEM, but they did not act.

Moreover, a high-ranking employee of the modern also signed articles that promoted the anti-Covid vaccine without revealing that he was working for the company, and posted promotion messages on social networks without declaring his affiliation, facts considered masked forms of advertising, contrary to the Ethics Code.

“Previous judgments have shown how easy the modern has put the profit before the health of the children. Now we see how little has respected the regulatory system meant to protect the public,” said Molly Kingsley, the founder of USForthem.

Modern, which joined the British pharmaceutical industry association only in 2023, has already accumulated ten new recent violations of the Ethics Code, and if the audit will confirm the lack of efficient compliance systems, the company risks suspension or even exclusion from the association – a rarely applied measure, only nine times.

In the last year, the modern was obliged to pay thousands of euros for violations of the regulations. Despite the financial sanctions imposed so far to the modern company, critics like Esther Mcvey, a former member of the parliamentary group for post-vaccination damages, point out that fines are insignificant compared to almost 7 billion pounds generated by modern in 2023, leaving the company few reasons to respect the rules.

Modern has told The Telegraph that it will not respond to these charges until the PMCPA decisions are published.